ORKA-003 / Oruka Therapeutics - LARVOL DELTA

Additional programs… (GlobeNewswire) - "(i) ORKA-021 (ORKA-002 → ORKA-001): Oruka continues to advance a sequential combination regimen of ORKA-002 and ORKA-001, which could deliver rapid and deep responses with an ideal maintenance profile. ORKA-021 could create another opportunity for the Company to define the best possible regimen for the treatment of psoriatic disease; (ii) ORKA-003: The Company continues to progress ORKA-003 through preclinical development."

Pipeline update • Psoriasis